• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者安全政策的优先级排序:日本患者安全专家使用德尔菲法调查。

Prioritization of patient safety health policies: Delphi survey using patient safety experts in Japan.

机构信息

Toho University School of Medicine, Tokyo, Japan.

All Japan Hospital Association, Tokyo, Japan.

出版信息

PLoS One. 2020 Sep 17;15(9):e0239179. doi: 10.1371/journal.pone.0239179. eCollection 2020.

DOI:10.1371/journal.pone.0239179
PMID:32941481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7497979/
Abstract

Various patient safety interventions have been implemented since the late 1990s, but their evaluation has been lacking. To obtain basic information for prioritizing patient safety interventions, this study aimed to extract high-priority interventions in Japan and to identify the factors that influence the setting of priority. Six perspectives (contribution, dissemination, impact, cost, urgency, and priority) on 42 patient safety interventions classified into 3 levels (system, organizational, and clinical) were evaluated by Japanese experts using the Delphi technique. We examined the relationships of the levels and the perspectives on interventions with the transition of the consensus state in rounds 1 and 3. After extracting the high-priority interventions, a chi-squared test was used to examine the relationship of the levels and the impact/cost ratio with high priority. Regression models were used to examine the influence of each perspective on priority. There was a significant relationship between the level of interventions and the transition of the consensus state (p = 0.033). System-level interventions had a low probability of achieving consensus. "Human resources interventions," "professional education and training," "medication management/reconciliation protocols," "pay-for performance (P4P) schemes and financing for safety," "digital technology solutions to improve safety," and "hand hygiene initiatives" were extracted as high-priority interventions. The level and the impact/cost ratio of interventions had no significant relationships with high priority. In the regression model, dissemination and impact had an influence on priority (β = -0.628 and 0.941, respectively; adjusted R-squared = 0.646). The influence of impact and dissemination on the priority of interventions suggests that it is important to examine the dissemination degree and impact of interventions in each country for prioritizing interventions.

摘要

自 20 世纪 90 年代末以来,已经实施了各种患者安全干预措施,但对其评估却一直不足。为了获得优先考虑患者安全干预措施的基本信息,本研究旨在从日本提取高优先级干预措施,并确定影响优先级设置的因素。使用德尔菲技术,日本专家对 42 项患者安全干预措施(分为 3 个级别:系统、组织和临床)的 6 个视角(贡献、传播、影响、成本、紧迫性和优先级)进行了评估。我们检查了干预措施的水平和视角与第 1 轮和第 3 轮共识状态转变之间的关系。在提取高优先级干预措施后,使用卡方检验检查干预措施的水平和影响/成本比与高优先级之间的关系。使用回归模型检查每个视角对优先级的影响。干预措施的水平与共识状态的转变之间存在显著关系(p = 0.033)。系统层面的干预措施达成共识的可能性较低。“人力资源干预措施”、“专业教育和培训”、“药物管理/协调协议”、“基于绩效的支付(P4P)计划和安全融资”、“提高安全性的数字技术解决方案”和“手部卫生倡议”被提取为高优先级干预措施。干预措施的水平和影响/成本比与高优先级之间没有显著关系。在回归模型中,传播和影响对优先级有影响(β=-0.628 和 0.941,分别;调整后的 R-squared=0.646)。影响和传播对干预措施优先级的影响表明,对于优先考虑干预措施,在每个国家检查干预措施的传播程度和影响非常重要。

相似文献

1
Prioritization of patient safety health policies: Delphi survey using patient safety experts in Japan.患者安全政策的优先级排序:日本患者安全专家使用德尔菲法调查。
PLoS One. 2020 Sep 17;15(9):e0239179. doi: 10.1371/journal.pone.0239179. eCollection 2020.
2
Difference in prioritization of patient safety interventions between experts and patient safety managers in Japan.日本专家和患者安全管理人员对患者安全干预措施的优先顺序存在差异。
PLoS One. 2023 Mar 1;18(3):e0280475. doi: 10.1371/journal.pone.0280475. eCollection 2023.
3
Identifying research priorities for patient safety in mental health: an international expert Delphi study.确定精神卫生领域患者安全的研究重点:一项国际专家德尔菲研究
BMJ Open. 2018 Mar 3;8(3):e021361. doi: 10.1136/bmjopen-2017-021361.
4
Patient safety priorities in mental healthcare in Switzerland: a modified Delphi study.瑞士精神卫生保健中的患者安全优先事项:一项改良德尔菲研究
BMJ Open. 2016 Aug 5;6(8):e011494. doi: 10.1136/bmjopen-2016-011494.
5
Key priority areas for patient safety improvement strategy in Libya: a protocol for a modified Delphi study.利比亚患者安全改善策略的关键优先领域:一项改良德尔菲研究方案
BMJ Open. 2017 Jul 2;7(6):e014770. doi: 10.1136/bmjopen-2016-014770.
6
Setting priorities for non-regulatory animal health in Ireland: results from an expert Policy Delphi study and a farmer priority identification survey.爱尔兰非监管动物健康优先事项的确定:专家政策德尔菲研究和农民优先事项识别调查的结果。
Prev Vet Med. 2010 Jul 1;95(3-4):198-207. doi: 10.1016/j.prevetmed.2010.04.011. Epub 2010 May 31.
7
A model for HTA priority setting: experience in Lithuania.卫生技术评估优先事项设定模型:立陶宛的经验
Int J Technol Assess Health Care. 2013 Oct;29(4):450-5. doi: 10.1017/S0266462313000470.
8
Priorities for pharmaceutical policies in developing countries: results of a Delphi survey.发展中国家药品政策的优先事项:德尔菲调查结果
Bull World Health Organ. 1994;72(2):257-64.
9
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.每伤残调整生命年成本信息对卫生优先排序的影响及登记册的理想特征:对越南、印度和孟加拉国卫生政策专家的调查
Health Res Policy Syst. 2016 Dec 3;14(1):86. doi: 10.1186/s12961-016-0156-6.
10
Defining and identifying concepts of medication reconciliation: An international pharmacy perspective.定义和识别药物重整概念:国际药学视角。
Res Social Adm Pharm. 2019 Jun;15(6):632-640. doi: 10.1016/j.sapharm.2018.07.020. Epub 2018 Aug 1.

引用本文的文献

1
Trends in public perceptions of patient safety during the COVID-19 pandemic: Findings from a repeated cross-sectional survey in Germany, 2019-2023.2019 - 2023年德国重复横断面调查结果:新冠疫情期间公众对患者安全认知的趋势
PLoS One. 2025 Aug 5;20(8):e0329761. doi: 10.1371/journal.pone.0329761. eCollection 2025.
2
Difference in prioritization of patient safety interventions between experts and patient safety managers in Japan.日本专家和患者安全管理人员对患者安全干预措施的优先顺序存在差异。
PLoS One. 2023 Mar 1;18(3):e0280475. doi: 10.1371/journal.pone.0280475. eCollection 2023.

本文引用的文献

1
Consensus on the exercise and dosage variables of an exercise training programme for chronic non-specific neck pain: protocol for an international e-Delphi study.慢性非特异性颈痛运动训练方案的运动和剂量变量共识:一项国际电子 Delphi 研究方案。
BMJ Open. 2020 May 15;10(5):e037656. doi: 10.1136/bmjopen-2020-037656.
2
Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan.日本药品/医疗器械经济评估官方指南的制定。
Value Health. 2017 Mar;20(3):372-378. doi: 10.1016/j.jval.2016.08.726. Epub 2016 Oct 21.
3
Development of an active behavioural physiotherapy intervention (ABPI) for acute whiplash-associated disorder (WAD) II management: a modified Delphi study.开发用于急性挥鞭样损伤相关疾病(WAD)II型管理的主动行为物理治疗干预(ABPI):一项改良的德尔菲研究。
BMJ Open. 2016 Sep 14;6(9):e011764. doi: 10.1136/bmjopen-2016-011764.
4
Patient Safety at the Crossroads.十字路口的患者安全。
JAMA. 2016 May 3;315(17):1829-30. doi: 10.1001/jama.2016.1759.
5
Evaluation of Nine Consensus Indices in Delphi Foresight Research and Their Dependency on Delphi Survey Characteristics: A Simulation Study and Debate on Delphi Design and Interpretation.德尔菲预测研究中九个共识指数的评估及其对德尔菲调查特征的依赖性:一项模拟研究及关于德尔菲设计与解释的辩论
PLoS One. 2015 Aug 13;10(8):e0135162. doi: 10.1371/journal.pone.0135162. eCollection 2015.
6
How effective are patient safety initiatives? A retrospective patient record review study of changes to patient safety over time.患者安全举措的效果如何?一项对患者安全随时间变化情况的回顾性患者记录审查研究。
BMJ Qual Saf. 2015 Sep;24(9):561-71. doi: 10.1136/bmjqs-2014-003702. Epub 2015 Jul 6.
7
Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies.定义共识:系统评价为 Delphi 研究报告推荐了方法学标准。
J Clin Epidemiol. 2014 Apr;67(4):401-9. doi: 10.1016/j.jclinepi.2013.12.002.
8
A new frontier in patient safety.患者安全的新领域。
JAMA. 2011 Jun 1;305(21):2221-2. doi: 10.1001/jama.2011.742.
9
Temporal trends in rates of patient harm resulting from medical care.医疗导致的患者伤害发生率的时间趋势。
N Engl J Med. 2010 Nov 25;363(22):2124-34. doi: 10.1056/NEJMsa1004404.
10
Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and Canada.利用有效性和成本效益来做出药物覆盖范围决策:英国、澳大利亚和加拿大的比较
JAMA. 2009 Oct 7;302(13):1437-43. doi: 10.1001/jama.2009.1409.